Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04075396
Title A Study of Lazertinib in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

lung non-small cell carcinoma

Therapies

Lazertinib

Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Advent Health Orlando Orlando Florida 32804 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Montefiore Medical Center Bronx New York 10461 United States Details
Tennessee Oncology Nashville Tennessee 37211 United States Details
Hosp. Univ. Vall D Hebron Barcelona 8035 Spain Details
Hosp. Gral. Univ. Gregorio Marañon Madrid 28009 Spain Details
Hosp. Virgen de La Victoria Malaga 29010 Spain Details
The Christie Nhs Foundation Trust Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field